To investigate the protective effects of
P2X7 receptor (P2X7R) inhibitor against
cerebral ischemia/reperfusion (I/R) injury in rats and the possible mechanisms.
Methods: The neurological deficit of rats was evaluated by Longa score. The
infarct volume was examined by 2, 3, 5-triphenyltetrazolium
chloride (TTC) staining. The expression levels of
extracellular signal-regulated kinase (ERK), phosphorylation extracellular signal-regulated kinas p-ERK),
connexin 43 (
Cx43), Bax, Bcl-2 and cleaved
caspase-3 were detected by Western blot.
Results: Compared with
sham group, the neurobehavioral score (P<0.05) and
cerebral infarct volume (P<0.01) of rats in I/R group was increased. Compared with I/R group,
brilliant blue G (BBG, the antagonist of P2X7R) or
PD98059 (the inhibitor of EKR
kinase) could reduce the neurobehavioral score (P<0.01) and
cerebral infarct volume significantly (P<0.05). The neurobehavioral score and
cerebral infarct volume was further decreased (P<0.05) when rats were treated with both BBG and
PD98059. Compared with I/R group, the expression levels of p-ERK,
Cx43, cleaved
caspase-3 and the ratio of Bax/Bcl-2 were decreased by BBG or
PD98059 pretreatment, and the protective effects were further enhanced when rats were treated with both BBG and
PD98059 (P<0.05).
Conclusion: Inhibition of P2X7R reduces the cerebral I/R injury of rats. ERK inhibition is probably involved in the protective effects of P2X7R inhibitor against cerebral I/R injury, which may be related to the reduction of
Cx43 and cleaved
caspase-3, and the ratio of Bax/Bcl-2.